Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 3
1962 2
1963 1
1965 1
1966 2
1967 6
1968 6
1970 9
1971 7
1972 5
1973 5
1974 11
1975 6
1976 1
1977 9
1978 11
1979 9
1980 5
1981 6
1982 4
1983 7
1984 9
1985 8
1986 5
1987 5
1988 3
1989 3
1990 4
1991 3
1992 4
1993 2
1994 5
1995 6
1996 7
1997 11
1998 8
1999 4
2000 8
2001 6
2002 8
2003 15
2004 8
2005 12
2006 19
2007 9
2008 9
2009 13
2010 11
2011 7
2012 6
2013 5
2014 7
2015 6
2016 10
2017 5
2018 12
2019 15
2020 11
2021 10
2022 10
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

412 results

Results by year

Filters applied: . Clear all
Page 1
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, Fukuda H, Endo M, Hattori A, Mimae T, Miyoshi T, Isaka M, Yoshioka H, Nakajima R, Nakagawa K, Okami J, Ito H, Kuroda H, Tsuboi M, Okumura N, Takahama M, Ohde Y, Aoki T, Tsutani Y, Okada M, Watanabe SI; Japan Clinical Oncology Group. Aokage K, et al. Lancet Respir Med. 2023 Jun;11(6):540-549. doi: 10.1016/S2213-2600(23)00041-3. Epub 2023 Mar 6. Lancet Respir Med. 2023. PMID: 36893780 Clinical Trial.
Rapamycin activates mammalian microautophagy.
Sato M, Seki T, Konno A, Hirai H, Kurauchi Y, Hisatsune A, Katsuki H. Sato M, et al. Among authors: katsuki h. J Pharmacol Sci. 2019 Jun;140(2):201-204. doi: 10.1016/j.jphs.2019.05.007. Epub 2019 May 24. J Pharmacol Sci. 2019. PMID: 31178328 Free article.
Anti-Parkinson drugs and orexin neurons.
Katsuki H, Michinaga S. Katsuki H, et al. Vitam Horm. 2012;89:279-90. doi: 10.1016/B978-0-12-394623-2.00015-9. Vitam Horm. 2012. PMID: 22640619 Review.
Nicotinic Acetylcholine Receptors in Regulation of Pathology of Cerebrovascular Disorders.
Katsuki H, Matsumoto K. Katsuki H, et al. 2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 7. 2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 7. PMID: 31314414 Free Books & Documents. Review.
Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann-Pick disease type C treatment.
Yamada Y, Fukaura-Nishizawa M, Nishiyama A, Ishii A, Kawata T, Shirakawa A, Tanaka M, Kondo Y, Takeo T, Nakagata N, Miwa T, Takeda H, Orita Y, Motoyama K, Higashi T, Arima H, Seki T, Kurauchi Y, Katsuki H, Higaki K, Minami K, Yoshikawa N, Ikeda R, Matsuo M, Irie T, Ishitsuka Y. Yamada Y, et al. Among authors: katsuki h. Clin Transl Med. 2023 Aug;13(8):e1350. doi: 10.1002/ctm2.1350. Clin Transl Med. 2023. PMID: 37620691 Free PMC article.
Tamibarotene: a candidate retinoid drug for Alzheimer's disease.
Fukasawa H, Nakagomi M, Yamagata N, Katsuki H, Kawahara K, Kitaoka K, Miki T, Shudo K. Fukasawa H, et al. Among authors: katsuki h. Biol Pharm Bull. 2012;35(8):1206-12. doi: 10.1248/bpb.b12-00314. Biol Pharm Bull. 2012. PMID: 22863914 Free article. Review.
412 results